📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
ANG LIFESCIENCES INDIA LIMITEDANGPharmaceuticals
Open
17.66
High
20.26
Low
17.66
Close
20.26
Volume
1998
Exchange
bse
Time
01-Apr-2026

Outlook

Score:  

2.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Ang Lifesciences India is  
Long Body
Estimated Stoploss of Ang Lifesciences India is ₹  
17.66
Ang Lifesciences India has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Ang Lifesciences India maybe  
Unpredictableℹ
, but keep a lookout for rise in price. 

Trend

Ang Lifesciences India is in  
Sideways trendℹ
. 
Price of Ang Lifesciences India is  
Downℹ
 by  

12.56

%. 
Target
Buy @ 

19.59

Sell @ 

29.03

Current @ 

20.26

Volume

The trade volumes of Ang Lifesciences India have become  
Deficientℹ
The volume trend for Ang Lifesciences India is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Ang Lifesciences India is  

Down

 by  

62.33

% 

Valuation

The current market price of Ang Lifesciences India is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 229cr and total assets worth ₹ 229cr, the balance sheet of Ang Lifesciences India is:  
Balancedℹ
. 
Cashflow
Ang Lifesciences India has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

0% in operatingℹ
50% i.e. ₹ 1cr spent in investingℹ
50% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Ang Lifesciences India has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

23.68% i.e. ₹ 9cr spent in operatingℹ
50% i.e. ₹ 19cr earned in investingℹ
26.32% i.e. ₹ 10cr spent in financingℹ
0% in otherℹ
Income
The income of Ang Lifesciences India is  

₹ 26cr

 and  

Loss

 is :  

₹ 2cr

(*Sep 2025)

Ang Lifesciences India Losses increased by:  

0

% and Income is Up by:  

8.33

% 

(*Sep 2025)

The income of Ang Lifesciences India is  

₹ 24cr

 and  

Loss

 is :  

₹ 2cr

(*Jun 2025)

Ang Lifesciences India Losses increased by:  

0

% and Income is Up by:  

41.18

% 

(*Jun 2025)

The income of Ang Lifesciences India is  

₹ 17cr

 and  

Loss

 is :  

₹ 2cr

(*Mar 2025)

Ang Lifesciences India Losses decreased by:  

60

% and Income is Down by:  

29.17

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.